Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma
Authors
Keywords
Hodgkins lymphoma, Radioimmunotherapy, Dosimetry, <sup>131</sup>I, Tenascin-C
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 41, Issue 5, Pages 867-877
Publisher
Springer Nature
Online
2014-01-17
DOI
10.1007/s00259-013-2658-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 0 Microdosing PET Study Using the Human Mini Antibody F16SIP in Head and Neck Cancer Patients
- (2013) D. A. Heuveling et al. JOURNAL OF NUCLEAR MEDICINE
- Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma
- (2012) A. Younes et al. BLOOD
- Treatment of newly diagnosed advanced stage Hodgkin lymphoma
- (2012) Jieun Uhm et al. BLOOD REVIEWS
- 90Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical Trial
- (2012) Christian W. Scholz et al. JOURNAL OF CLINICAL ONCOLOGY
- Radioimmunotherapy with Radretumab in Patients with Relapsed Hematologic Malignancies
- (2012) P. A. Erba et al. JOURNAL OF NUCLEAR MEDICINE
- Radioimmunotherapy in follicular lymphoma
- (2011) Tim Illidge et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- How I treat relapsed and refractory Hodgkin lymphoma
- (2011) J. Kuruvilla et al. BLOOD
- Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
- (2011) Christian Steidl et al. JOURNAL OF CLINICAL ONCOLOGY
- Connective Tissue Growth Factor Is Expressed in Malignant Cells of Hodgkin Lymphoma but Not in Other Mature B-Cell Lymphomas
- (2010) Anna Birgersdotter et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma
- (2010) Adam Jona et al. BLOOD REVIEWS
- The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape
- (2010) Donatella Aldinucci et al. JOURNAL OF PATHOLOGY
- Does Rituximab Have a Place in Treating Classic Hodgkin Lymphoma?
- (2010) Yasuhiro Oki et al. Current Hematologic Malignancy Reports
- Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients
- (2009) S. Sauer et al. BLOOD
- Inflammation and tissue repair markers distinguish the nodular sclerosis and mixed cellularity subtypes of classical Hodgkin's lymphoma
- (2009) A Birgersdotter et al. BRITISH JOURNAL OF CANCER
- Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma
- (2009) A. Younes Hematology-American Society of Hematology Education Program
- Managing relapsed and refractory Hodgkin lymphoma
- (2008) Pauline Brice BRITISH JOURNAL OF HAEMATOLOGY
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started